The Biologics Revolution in the Production of Drugs, spotlights the emerging science of biologic medicines, which involve genetically engineering living cells to produce needed proteins. Biologics have shown great promise in the treatment, diagnosis and prevention of more than 250 diseases including a variety of cancers. The study finds that Canada’s protection of intellectual property (IP) for biologic medicines lags behind other countries, limiting access and stunting investment.
No comments:
Post a Comment